1.Efficacy and safety of huperzine A in treating patients with mild cognitive impairment: a systematic review and Meta-analysis.
Po HUANG ; Bo LI ; Yu-Hong GUO ; Shuo FENG ; Jing HU ; Qing-Quan LIU
China Journal of Chinese Materia Medica 2019;44(3):582-588
To evaluate the efficacy and safety of huperzine in treating patients with mild cognitive impairment. The randomized controlled trials(RCT) were retrieved from EMbase, Cochrane Library, PubMed, CNKI, Wanfang and VIP. The methodology quality of the included studies was evaluated, and a Meta-analysis was performed using RevMan 5.3 software. A total of nine RCTs were included. The Meta-analysis results showed that compared with placebo, Huperzine significantly increased the scores of memory quotient(MQ) and mini-mental state examination(MMSE). However, there was no statistical difference between oral tablet and capsule. Compared with placebo, huperzine A was superior in the scores of MQ and MMSE. Huperzine is safe with mild side effects. Due to the low quality of original studies, more high-quality studies are needed to verify its efficacy.
Alkaloids
;
therapeutic use
;
Cognitive Dysfunction
;
drug therapy
;
Humans
;
Memory
;
Randomized Controlled Trials as Topic
;
Sesquiterpenes
;
therapeutic use
2.Elemene Antitumor Drugs Development Based on "Molecular Compatibility Theory" and Clinical Application: A Retrospective and Prospective Outlook.
Xiao-Ying JIANG ; Li-Ping SHI ; Jun-Long ZHU ; Ren-Ren BAI ; Tian XIE
Chinese journal of integrative medicine 2024;30(1):62-74
Elemene, derived from Curcuma wenyujin, one of the "8 famous genuine medicinal materials of Zhejiang province," exhibits remarkable antitumor activity. It has gained wide recognition in clinical practice for effectiveness on tumors. Dr. XIE Tian, introduced the innovative concept of "molecular compatibility theory" by combining Chinese medicine principles, specifically the "monarch, minister, assistant, and envoy" theory, with modern biomedical technology. This groundbreaking approach, along with a systematic analysis of Chinese medicine and modern biomedical knowledge, led to the development of elemene nanoliposome formulations. These novel formulations offer numerous advantages, including low toxicity, well-defined composition, synergistic effects on multiple targets, and excellent biocompatibility. Following the principles of the "molecular compatibility theory", further exploration of cancer treatment strategies and methods based on elemene was undertaken. This comprehensive review consolidates the current understanding of elemene's potential antitumor mechanisms, recent clinical investigations, advancements in drug delivery systems, and structural modifications. The ultimate goal of this review is to establish a solid theoretical foundation for researchers, empowering them to develop more effective antitumor drugs based on the principles of "molecular compatibility theory".
Humans
;
Retrospective Studies
;
Antineoplastic Agents/therapeutic use*
;
Neoplasms/drug therapy*
;
Drugs, Chinese Herbal/therapeutic use*
;
Sesquiterpenes/therapeutic use*
3.Progress of study on treatment of Alzheimer's disease with active ingredients of Chinese herbal medicines.
Chinese Journal of Integrated Traditional and Western Medicine 2008;28(2):177-181
In order to advance the treatment of Alzheimer's disease with active ingredients of Chinese herbal medicines and the research on these ingredients and their effective targets in treating the disease, the relative representative literatures published in recent years were reviewed and summarized in this paper.
Alkaloids
;
Alzheimer Disease
;
drug therapy
;
Drugs, Chinese Herbal
;
chemistry
;
therapeutic use
;
Ginkgo biloba
;
chemistry
;
Ginsenosides
;
therapeutic use
;
Humans
;
Phytotherapy
;
methods
;
trends
;
Salvia miltiorrhiza
;
chemistry
;
Sesquiterpenes
;
therapeutic use
4.Experimental study on protective effects of HupA in the treatment of isocarbophos poisoning.
Li LIU ; Guang-yun XIE ; Jian WANG ; Jin-xiu SUN
Chinese Journal of Industrial Hygiene and Occupational Diseases 2006;24(6):323-325
OBJECTIVETo investigate the therapeutic and prophylactic efficiency of HupA in mice with acute isocarbophos poisoning, and the protective effects of the HupA on AChE inhibited by isocarbophos.
METHODSMice were randomizedly divided into the non-treatment group, the atropine control group, the HupA treatment group and the atropine and HupA combined treatment group. Toxic signs and survival rates were observed and compared among these groups. The AChE activity was monitored in the whole blood, the red cells and brain tissue exposed to isocarbophos in the either treated with HupA or non-treated groups.
RESULTSIn HupA treatment group compared with the non-treatment group, toxic signs were significantly decreased and the survival rate was increased. The therapeutic efficiency in the atropine and HupA combined treatment group was better than other groups. After isocarbophos was administered, the AChE activity in the HupA treatment group and the non-treatment group was decreased. However, the AChE activity in the whole blood (1.096 +/- 0.111), (1.262 +/- 0.146), (1.181 +/- 0.353) U/ml, the red cells (0.798 +/- 0.063), (1.000 +/- 0.176), (0.837 +/- 0.331) and the brain tissue (13.739 +/- 2.970), (18.507 +/- 3.466), (10.764 +/- 2.212) U/g in HupA treatment group 0.5, 1 and 2 hours after isocarbophos was administered was significantly higher than those in the non-treatment group (P < 0.05 or P < 0.01).
CONCLUSIONHupA has therapeutic effect on mice with acute isocarbophos poisoning. The protective effect of HupA on blood and brain AChE inhibited by isocarbophos may be one of the mechanisms of the therapeutic effect of HupA in acute Isocarbophos poisoning.
Acetylcholinesterase ; blood ; metabolism ; Alkaloids ; Animals ; Brain ; enzymology ; Cholinesterase Inhibitors ; therapeutic use ; Insecticides ; poisoning ; Malathion ; poisoning ; Male ; Mice ; Mice, Inbred Strains ; Poisoning ; drug therapy ; Random Allocation ; Sesquiterpenes ; therapeutic use
5.Meta-analysis on elemene injection combined with cisplatin chemotherapeutics in treatment of non-small cell lung cancer.
Xiao-Wei XU ; Zheng-Zhong YUAN ; Wen-Hao HU ; Xiao-Kai WANG
China Journal of Chinese Materia Medica 2013;38(9):1430-1437
To research databases of Cochrane library, Web of Science, PubMed, FMJS, CBM, VIP, CNKI and Wanfang Data Konwledge Service Platform by computers as at July 5, 2012, which was supplemented with other search results. The findings were included into randomized controlled trials (RCTs) of elemene injection combined with cisplatin chemotherapeuties in treating small cell lung cancer (NSCLC). Data was separately collected by two researchers for literature quality evaluation, and a Meta analysis was made with RevMan 5. 2 software, in order to assess the efficacy and safety of elemene injection combined with cisplatin chemotherapeutics in treating NSCLC. Totally 11 RCTs or 844 cases were included. Meta analysis results suggested that compared with cisplatin chemotherapy alone, the combination of elemene injection and cisplatin chemotherapeutics showed a higher clinical benefit rate ( OR = 2. 03, 95% CI:1.43-2. 88, P <0. 000 1) and a better quality of life (OR = 3.23, 95% CI:2. 20-4. 74, P <0. 000 01). Besides,the combination could also reduce leucopenia (OR =0. 50, 95% CI:0. 33-0. 76, P <0. 001) , and thrombocytopenia (OR =0. 38, 95% CI:0. 16-0. 85, P <0. 02), increase CD4 (MD = 3.32, 95% C1:2. 94-3.70, P <0. 000 01), and CD4/CD8 (MD = 0. 36, 95% CI:0. 28-0. 44, P < 0. 000 01) , and relieve gastrointestinal reactions such as nausea and vomiting (OR = 0. 37, 95% CI: 0. 19-0. 71, P = 0. 003). The analysis indicates that elemene can enhance the chemotherapeutic effect on NSCLC, improve the quality of life, and reduce adverse effect of platinum-contained chemotherapeutics, thereby being worth promoting in clinic.
Carcinoma, Non-Small-Cell Lung
;
drug therapy
;
Cisplatin
;
administration & dosage
;
therapeutic use
;
Humans
;
Injections
;
Randomized Controlled Trials as Topic
;
Sesquiterpenes
;
administration & dosage
;
therapeutic use
6.Study on effect of Cordyceps sinensis and artemisinin in preventing recurrence of lupus nephritis.
Chinese Journal of Integrated Traditional and Western Medicine 2002;22(3):169-171
OBJECTIVETo observe the effect of Cordyceps sinensis and artemisinin in preventing recurrence of lupus nephritis (LN).
METHODSSixty-one LN patients, who had no activities by corticosterone and cyclophosphamide (CTX) impacting therapy were randomly divided into two groups. The 31 cases in the treated group were given Cordyceps powder 2-4 g/d before meal and artemisinin 0.6 g/d after meal in three portions orally taken for 3 years. The 30 patients in the control group were treated with tripterygiitotorum and/or Baoshenkang tablet. The consecutive observation lasted for 5 years to monitor the clinical manifestations of lupus and laboratory indexes including blood creatinine, creatinine clearance rate (CCr) and antinuclear antibodies (ANA).
RESULTSThe therapeutic effect showed markedly effective in 26 cases (83.9%), effective in 4 (12.9%) and ineffective in 1 (3.2%) in the treated group, while in the control group, the corresponding numbers were 15 (50.0%), 8 (26.7%) and 7 (23.3%), the difference between the two groups in markedly effective rate was significant (P < 0.01). In the treated group, C3 level was stabilized at above 1.21 +/- 0.20 g/L, which was over the normal range, CCr was unchanged as compared before and after treatment, which was significantly different from that in the control group. Moreover, the side-effects occurred in the treated group was less.
CONCLUSIONCordyceps and artemisinin could prevent the recurrence of LN and protect kidney function.
Adult ; Aged ; Anti-Infective Agents ; therapeutic use ; Artemisinins ; therapeutic use ; Complement C3 ; metabolism ; Cordyceps ; Creatinine ; blood ; Drug Therapy, Combination ; Drugs, Chinese Herbal ; therapeutic use ; Female ; Humans ; Lupus Nephritis ; drug therapy ; Male ; Middle Aged ; Phytotherapy ; Secondary Prevention ; Sesquiterpenes ; therapeutic use
7.Effect of parthenolide on serum expressions of interleukin-1beta and tumor necrosis factor-alpha in rabbits with knee osteoarthritis.
Fang-Xiao ZHU ; Run-Hua ZHOU ; Yu-Hong SHI ; Yang QIN
Chinese Journal of Integrated Traditional and Western Medicine 2013;33(10):1382-1384
OBJECTIVETo observe the therapeutic effect of parthenolide (PTL) on rabbit knee arthritis (KOA) and its effects on serum expression of interleukin-1beta (IL-1beta) and contents of tumor necrosis factor-alpha (TNF-alpha).
METHODSEight rabbits were randomly selected from 40 healthy pure-bred New Zealand rabbits as the normal control group. The KOA model was established in the rest 32 rabbits by plaster cast fixation of the right hind limb extension position. After modeling they were randomly divided into 4 groups, i.e., the model control group, the high dose PTL group, the middle dose PTL group, and the low dose PTL group, 8 in each group. Serum contents of IL-1beta and TNF-alpha were detected using enzyme-linked immunosorbent assay.
RESULTSCompared with the model group, IL-1beta and TNF-alpha concentration decreased in the 3 PTL groups (P < 0.01). The decrement was positively correlated with PTL concentrations (IL-1beta: r = 0.55, P < 0.01; TNF-alpha: r = 0.56, P < 0.01). The inhibition reached the peak when the PTL concentration arrived at 20 micromol/L.
CONCLUSIONSPTL could down-regulate the blood IL-1beta and TNF-alpha concentrations of KOA rabbits. Besides, the decrement was positively correlated with the PTL concentration.
Animals ; Female ; Interleukin-1beta ; blood ; Male ; Osteoarthritis, Knee ; blood ; drug therapy ; Phytotherapy ; Rabbits ; Sesquiterpenes ; pharmacology ; therapeutic use ; Tumor Necrosis Factor-alpha ; blood
8.Severe Adverse Reactions Induced by the Chest Injection of Elemene: An Analysis of 7 Cases.
Fei GAO ; Yi SHAO ; Diansheng ZHONG ; Xia LIU ; Fanlu MENG
Chinese Journal of Lung Cancer 2018;21(6):458-462
BACKGROUND:
Malignant pleural effusion (MPE) refers to pleural effusion which arises from primary malignant tumor of pleura or other pleural metastatic tumors. Injection of elemene in chest makes good effect on the treatment of MPE, and is widely used in clinic. Adverse effects also exist, but the severe adverse effects and relevant managements are rarely reported. The aim of this study is to observe the adverse reactions induced by the treatment of malignant pleural effusion through elemene injection and to explore the solutions.
METHODS:
A retrospective analysis was made on 14 cases of patients receiving intra-pleural injections with elemene, and the incidence of severe adverse reactions of 7 cases were disscussed in detail.
RESULTS:
Most of the severe adverse reactions caused by elemene were severe chest pain, dyspnea, wheezing, clouding of consciousness and coagulopathy.
CONCLUSIONS
Strict screening, full preprocessing and close monitoring are necessary to prevent serious adverse reactions caused by elemene injection in the treatment of malignant pleural effusion.
Aged
;
Female
;
Humans
;
Injections
;
Male
;
Middle Aged
;
Pleural Effusion, Malignant
;
drug therapy
;
Retrospective Studies
;
Sesquiterpenes
;
administration & dosage
;
adverse effects
;
therapeutic use
;
Thorax
9.β-caryophyllene alleviates cerebral ischemia/ reperfusion injury in mice by activating autophagy.
Jiang-Yan RAO ; Qian WANG ; Yu-Chun WANG ; Fei XIANG ; Xiao-Cui TIAN ; Dao-Hang LIU ; Zhi DONG
China Journal of Chinese Materia Medica 2020;45(4):932-936
Cerebral ischemia-reperfusion(I/R) injury is an important cause of acute ischemic stroke. Timely elimination of damaged proteins and organelles by regulating autophagy during cerebral ischemia-reperfusion plays an important role in relieving brain damage. In order to investigate whether β-caryophyllene(BCP) could protect neurons from cerebral I/R injury by regulating auto-phagy, C57 BL/6 J male mice were randomly divided into sham operation group, model group, and drug-administered group. After intra-gastric administration was given for 5 days, the middle cerebral artery occlusion(MCAO) model was established by suture method. Twenty four hours after surgery, the infarct volume and neurological function were assessed; the pathological changes of cortical tissue were observed by HE staining; Western blot was used to detect the expression of autophagy-related proteins beclin1, p62, LC3 B and apoptosis-related protein Bcl-2; immunofluorescence was used to observe the expression of LC3 B in the ischemic cortex. The autophagy of cortical tissue in the ischemic area was observed by transmission electron microscopy. The experimental results showed that as compared with the model group, the BCP pretreatment significantly reduced the neurological deficit, decreased the percentage of cerebral infarction volume, reduced the death of brain tissue cells in the ischemic area, up-regulated the expression of beclin1, LC3 B and Bcl-2 protein, down-regulated p62 protein expression, and significantly increased the number of autophagosomes in the cortical tissue of the ischemic area. It was finally determined that BCP could protect neurons from cerebral ischemia-reperfusion injury by activating autophagy.
Animals
;
Autophagy
;
Brain Ischemia/drug therapy*
;
Infarction, Middle Cerebral Artery
;
Male
;
Mice
;
Mice, Inbred C57BL
;
Polycyclic Sesquiterpenes/therapeutic use*
;
Random Allocation
;
Reperfusion Injury/drug therapy*
10.Research progress in Laggera medicinal plants.
Chang-Xin ZHOU ; Di-Yao WU ; Xiang-Ping LI ; Yi-Hang WU ; Jun ZHAO ; Nan DONG ; Rong-Min YU ; Wei WEI ; Qun-Xiong ZHENG ; Han-Dong SUN ; Xiao-Jiang HAO ; Yu ZHAO
China Journal of Chinese Materia Medica 2006;31(14):1133-1140
This paper reviewed the worldwide research progresses of the genus Laggera both on phytochemical and pharmacological work in the past few decades. The main secondary metabolites of this genus are proved to be sesquitepenoids, flavonoids and phenolic acids. Phamacological investigations revealed that the certain extracts of some Laggera species possess significant bioactivities on anti-inflammation, anti-tumor and anti-viral infection. This review afforded the comprehensive description of the active components as to provide useful references to elucidate their historical clinical application on upper respiratory infection, influenza, parotitis, and recurrent herpes viral infection.
Animals
;
Anti-Inflammatory Agents, Non-Steroidal
;
pharmacology
;
therapeutic use
;
Antineoplastic Agents, Phytogenic
;
pharmacology
;
therapeutic use
;
Antiviral Agents
;
pharmacology
;
therapeutic use
;
Flavonoids
;
chemistry
;
isolation & purification
;
therapeutic use
;
Humans
;
Influenza, Human
;
drug therapy
;
Molecular Structure
;
Parotitis
;
drug therapy
;
Phytotherapy
;
Plants, Medicinal
;
chemistry
;
Ranunculaceae
;
chemistry
;
Respiratory Tract Infections
;
drug therapy
;
Sesquiterpenes
;
chemistry
;
isolation & purification
;
therapeutic use